Dishman is a multinational pharmaceutical company headquartered in Ahmedabad, India and listed on the Bombay Stock Exchange. The company's biggest assets are goodwill, which increased 6.17% year-over-year to 44.8% of total revenue, and property, plant and equipment, which rose 11.67% to 20.8% of revenue. Its main liabilities are borrowings, up 32.3% to 8.3% of revenue, and other financial liabilities, which grew 12.7% to 3.6% of revenue. Dishman's primary equity is other equity, which increased 6.7% but fell as a percentage of total revenue to 69.4%.
Dishman is a multinational pharmaceutical company headquartered in Ahmedabad, India and listed on the Bombay Stock Exchange. The company's biggest assets are goodwill, which increased 6.17% year-over-year to 44.8% of total revenue, and property, plant and equipment, which rose 11.67% to 20.8% of revenue. Its main liabilities are borrowings, up 32.3% to 8.3% of revenue, and other financial liabilities, which grew 12.7% to 3.6% of revenue. Dishman's primary equity is other equity, which increased 6.7% but fell as a percentage of total revenue to 69.4%.
Dishman is a multinational pharmaceutical company headquartered in Ahmedabad, India and listed on the Bombay Stock Exchange. The company's biggest assets are goodwill, which increased 6.17% year-over-year to 44.8% of total revenue, and property, plant and equipment, which rose 11.67% to 20.8% of revenue. Its main liabilities are borrowings, up 32.3% to 8.3% of revenue, and other financial liabilities, which grew 12.7% to 3.6% of revenue. Dishman's primary equity is other equity, which increased 6.7% but fell as a percentage of total revenue to 69.4%.